Why Investors Are Flocking to the AbbVie Bond Sale

The transcript discusses the recent surge in bond market activity, highlighting a significant upsizing of deals due to high demand. Factors such as reduced issuance, tax changes, and high returns are driving this demand. The state of credit markets is strong, with both investment-grade and junk bonds seeing activity. Regulatory reviews are ongoing, but companies are taking advantage of favorable market conditions. AbbVie's financial metrics are under scrutiny due to increased debt, but investor trust remains due to the company's high cash flow.

What was the initial amount intended to be raised in the bond deal before it was upsized?

• 70 billion

• 45 billion

• 30 billion

• 28 billion

Why are investors particularly interested in high-quality bonds this year?

• Returns are at their highest in 10 years

• Investment grade bonds are scarce

• Tax changes have increased issuance

• Issuance is up by 5%

What is a notable trend in the junk bond market according to the transcript?

• The market is unaffected by interest rates

• Investors are demanding higher pricing

• There is a decrease in the number of deals

• Investors are accepting lower premiums

What is the current status of the deal under review by US antitrust officials?

• It has been blocked

• It is expected to close early next year

• It has been approved

• It is closing this week

How does AbbVie plan to manage its high debt level?

• By reducing its cash flow

• By issuing more bonds

• By increasing its leverage ratio

• By quickly lowering its leverage ratio